Orthocell Limited (ASX:OCC)
Australia
· Delayed Price · Currency is AUD 1.410
-0.050 (-3.42%)
Feb 21, 2025, 4:10 PM AEST
Orthocell Revenue
In the fiscal year ending June 30, 2024, Orthocell had annual revenue of 5.32M AUD with 25.27% growth. Orthocell had revenue of 3.91M in the half year ending June 30, 2024, with 409.36% growth.
Revenue
5.32M
Revenue Growth
+25.27%
P/S Ratio
53.59
Revenue / Employee
n/a
Employees
n/a
Market Cap
338.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 5.32M | 1.07M | 25.27% |
| Jun 30, 2023 | 4.24M | 2.71M | 177.01% |
| Jun 30, 2022 | 1.53M | 513.76K | 50.47% |
| Jun 30, 2021 | 1.02M | 298.44K | 41.48% |
| Jun 30, 2020 | 719.52K | -226.13K | -23.91% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 16.66B |
| Ansell | 3.00B |
| Mesoblast | 8.85M |
Orthocell News
- 2 months ago - Perth’s billionaire set is piling into this little-known medtech - The Australian Financial Review